Resources
Read the full media alert >> BOSTON–(BUSINESS WIRE)–OM1: What: OM1, the leader in real-world data and AI-driven insights in mental health for life sciences, announced an upcoming poster presentation hosted by Jessica Probst, OM1’s Principal, Real World Evidence. The poster focuses on the linkage between Glucagon-like Peptide 1 Receptor Agonists (GLP-1s) and Suicidal Ideation (SI).[…]
Register >> June 26, 2025 2:30pm ET Mental health conditions can take a significant toll on an individual—physically, socially, and financially. Despite new treatment options becoming available, many patients still continue to struggle with finding effective solutions. Frustratingly, even treatments with strong efficacy won’t work for everyone – and it’s very hard to know in advance[…]
Apr 22, 2025 9:01 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leader in real-world data and AI-driven insights for mental health, today announced a significant expansion of its specialty mental health network, adding over one million patients, making it the largest, most clinically rich network of its kind. This milestone deepens OM1’s ability to power[…]
Register >> Thursday, May 8, 2025 | 12:00-1:00PM EST As drug development becomes more complex and personalized, traditional randomized controlled trials (RCTs) are no longer sufficient to answer every research question—particularly in rare diseases, and situations lacking head-to-head comparisons. Regulators, payers and other stakeholders are increasingly turning to real-world evidence (RWE) to address the gaps,[…]
April 2019 Significant variation exists in both the types and definitions of outcome measures used in patient registries, even within the same clinical area. This variation reduces the utility of registries, making it difficult to compare, link, and aggregate data across the spectrum of clinical care and reporting. To address these limitations, the Agency for[…]
